Literature DB >> 24964349

Complementary and alternative medicine use among patients with psoriasis.

Katerina Damevska1, Lence Neloska, Suzana Nikolovska, Gorgi Gocev, Silvia Duma.   

Abstract

Despite the growing attention on safety and efficacy of conventional treatments, there is little information available on complementary and alternative medicine (CAM) used in psoriasis. In order to collect comprehensive information on CAM use, we conducted a face-to-face interview with 122 patients with psoriasis. All unconventional treatments for psoriasis used in the last 12 months were recorded. Fifty-seven patients (46.7%) used one of the CAM methods in the previous year, including topical and systemic antipsoriatics, dietary supplements, and diet. Forty-one different nonconventional topical treatments were used. Seven patients (5.7%) took nonconventional systemic medication, and 15.5% used dietary supplements. There were three patients who reported current adherence to a diet as treatment of psoriasis. Clinicians are often not informed that their patients are using complementary therapies. CAM may offer benefits as well as risks to patients with psoriasis. It is important to remind patient to report all ongoing and past topical and systemic treatments. The use of medications with unknown composition, efficiency, and safety should be discouraged.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  complementary and alternative medicine; psoriasis

Mesh:

Substances:

Year:  2014        PMID: 24964349     DOI: 10.1111/dth.12139

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  8 in total

1.  Complementary and Alternative Medicine Use in Patients With Hidradenitis Suppurativa.

Authors:  Kyla N Price; Alyssa M Thompson; Omar Rizvi; Aleksi J Hendricks; Afsaneh Alavi; Jennifer L Hsiao; Vivian Y Shi
Journal:  JAMA Dermatol       Date:  2020-03-01       Impact factor: 10.282

2.  Considerations for practice-based research: a cross-sectional survey of chiropractic, acupuncture and massage practices.

Authors:  Lysbeth Floden; Amy Howerter; Eva Matthews; Mark Nichter; James K Cunningham; Cheryl Ritenbaugh; Judith S Gordon; Myra L Muramoto
Journal:  BMC Complement Altern Med       Date:  2015-05-02       Impact factor: 3.659

3.  Ethnopharmacological survey of medicinal plants used by patients with psoriasis in the West Bank of Palestine.

Authors:  Ramzi Shawahna; Nidal Amin Jaradat
Journal:  BMC Complement Altern Med       Date:  2017-01-03       Impact factor: 3.659

Review 4.  Apoptotic or Antiproliferative Activity of Natural Products against Keratinocytes for the Treatment of Psoriasis.

Authors:  Tse-Hung Huang; Chwan-Fwu Lin; Ahmed Alalaiwe; Shih-Chun Yang; Jia-You Fang
Journal:  Int J Mol Sci       Date:  2019-05-24       Impact factor: 6.208

5.  Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open-label randomized comparative pilot clinical study.

Authors:  P Alex; S Williams; L Sutton; T Yesudas; C Sutton; S Thomas; M Centola
Journal:  Clin Exp Dermatol       Date:  2019-09-26       Impact factor: 3.470

6.  2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From Antrodia cinnamomea, Mitigates Psoriasiform Inflammation by Suppressing MAPK/NF-κB Phosphorylation and GDAP1L1/Drp1 Translocation.

Authors:  Shih-Yi Chuang; Chi-Yuan Chen; Shih-Chun Yang; Ahmed Alalaiwe; Chih-Hung Lin; Jia-You Fang
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

7.  The use of complementary and alternative medicine by patients suffering from psoriasis and psoriatic arthritis.

Authors:  Aleksandra Wnuk-Kłosiǹska; Ewelina Bielanowska; Zygmunt Adamski; Rafał Czajkowski; Dorota Jenerowicz
Journal:  Postepy Dermatol Alergol       Date:  2020-10-21       Impact factor: 1.837

8.  Xiao-Yin-Fang Therapy Alleviates Psoriasis-like Skin Inflammation Through Suppressing γδT17 Cell Polarization.

Authors:  Xilin Zhang; Xiaorui Li; Youdong Chen; Bingjie Li; Chunyuan Guo; Peng Xu; Zengyang Yu; Yangfeng Ding; Yuling Shi; Jun Gu
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.